Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	226.65	77.39	170.2	62.53	50.19
Short-Term Investments	90.33	99.11	201.16	284.42	45.93
Cash & Short-Term Investments	316.98	176.5	371.36	346.95	96.12
Cash Growth	79.59%	-52.47%	7.04%	260.96%	646.43%
Accounts Receivable	0.09	0.45	40.05	15.31	-
Inventory	-	-	38.32	9.77	-
Other Current Assets	6.6	12.48	14.93	10.11	8.83
Total Current Assets	323.67	189.43	464.67	382.13	104.95
Net Property, Plant & Equipment	5.49	2.73	6.41	8.14	0.47
Other Long-Term Assets	3.48	1.47	46.38	1.19	0.19
Total Assets	332.65	193.63	517.45	391.45	105.61
Accounts Payable	3.52	2.94	22.06	6.26	4.37
Accrued Expenses	17.91	23.95	57.72	38.31	13.02
Current Portion of Leases	1.26	1.52	2.26	2.04	-
Total Current Liabilities	22.69	28.41	82.04	46.61	17.4
Long-Term Leases	4.7	0.46	1.98	4.24	-
Other Long-Term Liabilities	-	-	-	-	0.04
Total Long-Term Liabilities	4.7	0.46	1.98	4.24	0.04
Total Liabilities	27.39	28.87	84.02	50.85	17.43
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	1,056	771.54	738.18	694.91	4.67
Accumulated Other Comprehensive Income	0.4	-0.09	0.2	-0.09	0.01
Retained Earnings	-751.43	-606.69	-304.95	-354.22	-155.85
Total Common Shareholders' Equity	305.26	164.77	433.43	340.61	-151.17
Minority Interest	-	-	-	-	239.35
Shareholders' Equity	305.26	164.77	433.43	340.61	88.18
Total Liabilities & Equity	332.65	193.63	517.45	391.45	105.61
Total Debt	5.96	1.98	4.24	6.28	0
Net Cash (Debt)	311.02	174.52	367.13	340.67	96.12
Net Cash Growth	78.22%	-52.46%	7.77%	254.43%	662.00%
Net Cash Per Share	3.29	2.56	5.25	5.82	14.59
Book Value	305.26	164.77	433.43	340.61	-151.17
Book Value Per Share	3.23	2.42	6.19	5.82	-22.95
Tangible Book Value	305.26	164.77	433.43	340.61	-151.17
Tangible Book Value Per Share	3.23	2.42	6.19	5.82	-22.95

Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q